YBX1 and urinary bladder carcinoma: Treatment with cisplatin also stimulates YB-1 production in bladder cancer (Shiota et al., 2010), while ovarian cancer cells with acquired cisplatin resistance show an increase in nuclear YB-1 expression (Yahata et al., 2002), suggesting that cancer cells may increase YB-1 production as a protective measure.